Headquartered in San Diego, California, Ferring Research Institute, Inc., (FRI) is the global peptide therapeutics research center for Ferring Pharmaceuticals.

Ferring first established a research group in San Diego in 1996, recognizing the vibrant opportunities in the region.  Since establishing a presence in San Diego, Ferring has been able to assemble a world-class peptide research organization and establish collaborations with leading academic scientists.

The Ferring Research Institute, Inc., moved to its new home in San Diego in February 2009 with the opening of a 38,000-square-foot facility in Sorrento Valley. The new state-of-the art facility research houses expanded research laboratories for peptide medicinal chemistry, biochemistry, bioanalytical, and pharmacology.

The small group of researchers working in San Diego has now grown to a staff of more than 70. In recent years the group developed five clinical compounds that have reached human clinical trials.

FRI is committed to building a portfolio of novel, innovative peptide therapeutics to address areas of high unmet medical need.